Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia

Oncoproteomics is an important innovation in the early diagnosis, management and development of personalized treatment of acute lymphoblastic leukaemia (ALL). As inherent factors are not completely known – e.g. age or family history, radiation exposure, benzene chemical exposure, certain viral expos...

Descripción completa

Detalles Bibliográficos
Autores principales: López Villar, Elena, Wang, Xiangdong, Madero, Luis, Cho, William C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288348/
https://www.ncbi.nlm.nih.gov/pubmed/25537633
http://dx.doi.org/10.1111/jcmm.12507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288348/
https://www.ncbi.nlm.nih.gov/pubmed/25537633
http://dx.doi.org/10.1111/jcmm.12507

Ejemplares similares